You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphomas

Showing 1 - 25 of 1,346
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHWD-870 in Advanced Solid Tumors or Lymphomas Carrying NUT

Recruiting
  • Advanced Solid Tumors or Lymphomas
  • Changsha, Hunan, China
    Hunan Provincal Tumor Hospital
Oct 5, 2023

EBV-associated Lymphomas Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell

Not yet recruiting
  • EBV-associated Lymphomas
  • (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
  • (no location specified)
May 31, 2023

Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

Not yet recruiting
  • Advanced Solid Tumors
  • B-cell Non-Hodgkin Lymphomas
  • (no location specified)
Aug 31, 2023

Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

Not yet recruiting
  • Relapsed or Refractory Lymphomas
  • Advanced Solid Tumor
  • Los Alamitos, California
    Cancer and Blood Specialty Clinic
Nov 9, 2023

Relapsed or Refractory T-cell Lymphomas Trial in Sendai-shi (BMS-986369)

Not yet recruiting
  • Relapsed or Refractory T-cell Lymphomas
  • Sendai-shi, Miyagi, Japan
    Local Institution - 0001
Sep 12, 2023

Circulating Tumor DNA Sequencing in Peripheral T-cell Lymphomas

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • circulating tumoral DNA detection
  • Rouen, France
    Centre Henri Becquerel
Oct 13, 2023

Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)

Not yet recruiting
  • Lymphomas
  • B-cell Lymphomas
  • Houston, Texas
    The University of Texas M D Anderson Cancer Center
Mar 6, 2023

Lymphoma Trial in Yerevan (Balstilimab)

Not yet recruiting
  • Lymphoma
  • Yerevan, Armenia
    Hematology Center named after prof. R. Yeolyan
May 26, 2023

Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)

Not yet recruiting
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Beijing, China
  • +3 more
Jul 20, 2023

Relapsed Advanced Lymphomas Trial in India (AUR108)

Not yet recruiting
  • Relapsed Advanced Lymphomas
  • Visakhapatnam, Andhra Pradesh, India
  • +8 more
Aug 9, 2023

T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • Hangzhou, Zhejiang, China
    The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023

Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma Trial in Shanghai (Phase I

Not yet recruiting
  • Has a Pathologically Documented Unresectable Locally Advanced or Metastatic Solid Tumor or Lymphoma
  • Phase I dose escalation
  • +3 more
  • Shanghai, Shanghai, China
    Fudan Cancer Hospital
Apr 24, 2023

COVID-19 Infection in Malignant Lymphomas Participating in

Completed
  • Malignant Lymphoma
  • +2 more
  • No intervention
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Apr 22, 2023

Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • Fungoides Mycosis Sezary Syndrome
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Jul 13, 2023

Solid Malignancies or Lymphomas Trial in Wollongong (IBI363)

Recruiting
  • Solid Malignancies or Lymphomas
  • IBI363
  • Wollongong, New South Wales, Australia
    Southern Medical Day Care Centre
Sep 4, 2022

Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • +3 more
  • Tazemetostat Pill
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023

Solid Tumor, Classic Hodgkin Lymphoma Trial in China (IMM01, Tislelizumab)

Recruiting
  • Solid Tumor
  • Classic Hodgkin Lymphoma
  • Hangzhou, China
  • +4 more
Apr 18, 2023

Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Duarte, California
  • +1 more
Oct 13, 2023

Lymphoma Trial in Houston (Ibritumomab Tiuxetan (Zevalin), Rituximab)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 30, 2022

Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)

Recruiting
  • Diffuse Large Cell Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Lymphomas Trial in Wuhan, Guangzhou, Shanghai (HMPL-689)

Active, not recruiting
  • Lymphomas
  • Wuhan, Hubei, China
  • +2 more
Sep 8, 2022

Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma Trial in Chicago, Boston, Omaha (Pembrolizumab)

Suspended
  • Lymphoma
  • +3 more
  • Chicago, Illinois
  • +3 more
Jan 30, 2023

Solid Advanced Tumor, Lymphoma Trial in Belgium, France (OSE-279 100mg, OSE-279 300mg, OSE-279 500mg)

Recruiting
  • Solid Advanced Tumor
  • Lymphoma
  • OSE-279 100mg
  • +2 more
  • Anderlecht, Belgium
  • +5 more
Feb 27, 2023

Advanced Solid Tumors or Lymphomas Trial in Beijing (JS019)

Recruiting
  • Advanced Solid Tumors or Lymphomas
  • JS019
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 9, 2022

[18F]-FDG PET/CT and PET/MRI in Lymphomas

Recruiting
  • PET/MRI
    • Beijing, Card Holder's Billing State / Province, China
      Peking University Cancer Hospital
    May 22, 2022